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Stroke is one of the leading causes of adult disability and the fourth leading cause of mortality in the US.
Stroke disproportionately occurs among the elderly, where the disease is more likely to be fatal or lead to
long-term supportive care. Animal models, where the ischemic insult can be controlled more precisely,
also conﬁrm that aged animals sustain more severe strokes as compared to young animals. Furthermore,
the neuroprotection usually seen in younger females when compared to young males is not observed in
older females. The preclinical literature thus provides a valuable resource for understanding why the
aging brain is more susceptible to severe infarction. In this review, we discuss the hypothesis that stroke
severity in the aging brain may be associated with reduced functional capacity of critical support cells.
Speciﬁcally, we focus on astrocytes, that are critical for detoxiﬁcation of the brain microenvironment
and endothelial cells, which play a crucial role in maintaining the blood brain barrier. In view of the
sex difference in stroke severity, this review also discusses studies of middle-aged acyclic females as well
as the effects of the estrogen on astrocytes and endothelial cells.
 2013 The Authors. Published by Elsevier Ltd.Open access under CC BY-NC-ND license.1. Introduction
Stroke is the 4th leading cause of death and the leading non-
martial cause of disability. The prevalence of stroke in the 60–
79 year old group is 6.2% for men and 6.9% for women, which prac-
tically doubles in the 80+ years age group, where the incidence is
13.9% for males and 13.8% of females (Go et al., 2013), indicating
that this disease disproportionately affects the elderly. Not surpris-
ingly, the incidence of hypertension, a principal risk factor for
stroke is also highly prevalent in this population estimated at
69.6% of all women aged 65–74, and 64.7% of all men aged 65–
74 (Go et al., 2013).
Besides an elevated risk for stroke, old age is also an adverse prog-
nosticator of stroke outcomes (Jongbloed, 1986), using several mea-
sures including survival, functional recovery, and hospitalization. In
an early study of 415 patients with transient ischemic attack (TIAs),
1 year and 5 year survival was negatively correlated with advanced
age (Howard et al., 1987). A prospective analysis of 515 stroke pa-
tients (Copenhagen Stroke Study), showed that outcome measuressuch as the activities of daily living (measured by the Barthel Index
[BI]) were signiﬁcantly worse in older patients, although neurologi-
cal outcomes were not affected by age (Nakayama et al., 1994), sug-
gesting a poorer ability to compensate among this older population.
Furthermore, hospitalization length was signiﬁcantly increased in
older patients (>65 years)with stroke (Qureshi et al., 2013). Observa-
tional studies in university-hospital settings reported that age was a
highly signiﬁcant predictor of poor functional outcome (Knoﬂach
et al., 2012; Denti et al., 2010; Abanto et al., 2013). Moreover, a small
study of centenarians also conﬁrmed that strokes were much more
severe in this population than in other age groups (Olsen and Ander-
sen, 2013). Morphologically, aging is associated with decreased sal-
vage of penumbral tissue, and leptomeningeal collateral circulation
is reduced in aging stroke patients and associated with a poorer out-
come (Arsava et al., 2013).
Because of longevity, projected stroke-related disability and
institutionalization is likely to affect women more than men (Lai
et al., 2005). Although earlier studies indicated that the increased
incidence of stroke in women did not occur until age 80, newer
studies suggest that the risk for stroke in middle aged women dou-
bles that of men (Towﬁghi et al., 2007). Furthermore, women ac-
count for 60% of stroke-related deaths (Lloyd-Jones et al., 2010),
even after normalization for age. A Canadian stroke registry study
reported that 10% of women stroke patients were discharged to
long term care as compared to 5% men (Kapral et al., 2005), despite
the observation that stroke size tends not to be different in males
and females (Silva et al., 2010). Finally, 5-year stroke recurrence is
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(10%) in the 45–64 age range (Roger et al., 2011). In the Danish Na-
tional Registry analysis, women were reported to have more severe
strokes than men although they exhibited a survival advantage
compared to men, especially at advanced ages (Olsen and Ander-
sen, 2010).
Age differences in stroke outcomes in preclinical models tend
to mirror the ﬁndings of the clinical studies. A comparison of
young and aged male and female mice subject to a middle cere-
bral artery occlusion (MCAo) revealed that young females sustain
a smaller infarct as compared to young males or aged female
mice (Liu et al., 2009) although by 2 weeks, both young and aged
groups were comparable (Manwani et al., 2011). In a study of
10d, 63d and 180d old animals, functional recovery was most
prominent in the neonate and was impaired in the older age
groups, suggesting that stroke-related recovery is best in the
immature brain (Yager et al., 2006). Similarly, post stroke epi-
lepsy, a common complication in this disease, was more common
in older animals as compared to younger ones (Kelly et al., 2001).
At the cellular level, aged animals are able to mount a cytoprotec-
tive response to stroke but the timing of glial and endothelial
proliferation is accelerated, resulting in rapid infarct development
and poor prognosis in aged animals (Popa-Wagner et al., 2007).
Biomarkers for stroke injury also appear to be age dependent. Ni-
tric oxide, for example, was reduced in plasma of aged stroke pa-
tients while it was elevated in younger and less severe cases, and
IL-6 was elevated in aged patients with a poor outcome (Shaka-
rishvili and Beridze, 2008). Additionally, stroke therapies may
also display age-dependent effectiveness. For example, the
NOX2 inhibitor apocynin reduces infarct volume in young ani-
mals while increasing infarct volume and edema in older animals
(Kelly et al., 2009). Similarly, the plasminogen activator inhibitor
type 1 derived peptide, EEIIMD, reduced infarct volume in both
young and old animals but did not reduce edema in old animals
(Tan et al., 2009).
Sex differences in stroke outcome are also well recognized in
preclinical models. Females have a smaller infarct and better cere-
bral blood ﬂow than age-matched males both in normoglycemic
(Alkayed et al., 1998) and diabetic (Toung et al., 2000) animals.
However, although female mice sustain a much smaller infarct as
compared to age matched males (Manwani et al., 2011), aged fe-
males showed signiﬁcantly more mortality and poorer stroke out-
comes as compared to older males. The female advantage seen in
young age demographics as well as animal models has led to the
hypothesis that estrogen, the major ovarian hormone, may be pro-
tective for stroke. Using natural variations in circulating estrogen
levels across the estrous cycle, Liao et al. (2001) showed that the
extent of ischemic damage was inversely related to circulating lev-
els of estrogen. In fact, replacement with 17b estradiol and its inac-
tive stereoisomer 17a estradiol (Simpkins et al., 1997) as well as
the conjugate equine estrogen preparation (McCullough et al.,
2001) all reduce infarct volume in female animals. Exogenous
estrogen replacement is neuroprotective when given prior (Dubal
et al., 1998) or subsequent to the injury (Liu et al., 2005; Yang
et al., 2003).
However, hormone effects are more complicated in the context
of aging. Hormone therapy at menopause is a speciﬁc concern for
stroke outcomes since this middle aged demographic is at in-
creased risk for stroke. Our studies have speciﬁcally addressed this
reproductive transition phase by studying acyclic, middle-aged fe-
male animals (Johnson et al., 2006; Selvamani and Sohrabji,
2010a,b). Reproductive senescent rats are characterized by repro-
ductive criteria including multiple previous successful pregnan-
cies, current reproductive failure, and constant diestrus (a low
estrogen state) as determined by vaginal smears. Plasma levels of
estradiol are low and FSH levels are elevated, consistent with amenopausal pattern. MCAo in this middle aged female results in
a signiﬁcantly larger infarct as compared to young females (Selva-
mani and Sohrabji, 2010a), suggesting that the loss of ovarian hor-
mones may accelerate age-related stroke severity. Furthermore,
estrogen treatment to ovariectomized reproductive senescent fe-
males paradoxically increases infarct volume, indicating that the
aging brain may be refractory to hormone mediated neuroprotec-
tion (Selvamani and Sohrabji, 2010a,b). This was conﬁrmed by an-
other study where long term estrogen replacement to aged females
also failed to improve stroke (Leon et al., 2012).
While the speciﬁc cause for age-related severity in stroke out-
comes is not clear, several theories abound. Stroke causes sprout-
ing of axons and reorganization of connections in the peri-infarct
area, which is associated with behavioral recovery. Sprouting is
hindered in the aged stroke animals, and a recent study shows that
the transcriptome of the sprouting neurons in aging animals differs
considerably from the sprouting neurons in young animals (Li
et al., 2010). Genes families such as cytokines, chemokines, growth
factors and axon guidance molecules were speciﬁcally affected
with age, as well as genes associated with the Nogo receptor-1
complex, which is associated with inhibition of axonal sprouting
in other injury models (Lee et al., 2004).
While the phenotype of the aging neuron will critically impact
stroke severity, neuronal survival will also be compromised by
age-related changes in brain support cells. This review will specif-
ically focus on the endothelium and astrocytes, their function in
ischemic stroke, and the impact of age on their protective
functions.
1.1. Endothelial cells
Endothelial cells are the principal component of the blood brain
barrier and the building block of microvascular capillary networks.
These cells play a central role in maintaining brain function and
repair.
Blood brain barrier: The blood brain barrier, which evolved to
regulate the inﬂux and efﬂux of cells, molecules and ions, consists
of closely apposed endothelial cells, supported by astrocytic end
feet and pericytes (Risau and Wolburg, 1990; Abbott et al., 2006;
Kulik et al., 2008; Haseloff et al., 2005). Among the many age-re-
lated changes in endothelial function, alterations in the blood brain
barrier are most likely to elevate the risk for stroke and severity.
Age-related changes in the microvasculature increases blood brain
barrier permeability (Kalaria, 1999; Abbott, 2000; Farrall and
Wardlaw, 2007; Grammas et al., 2011) although the reasons
underlying this change are not known. In humans, normal aging
is associated with increased blood brain barrier permeability and
is further increased in patients with vascular dementia and Alzhei-
mer’s disease (Farrall and Wardlaw, 2007).
Blood brain barrier disruption enhances inﬁltration of serum
proteins into brain parenchyma (Loftspring et al., 2006) and trig-
gers an inﬂammatory response. Chief among the features that pro-
mote barrier function in cerebral endothelial cells are the presence
of tight junctions between adjacent cells that effectively modulates
the passage of ions and nutrients as well as acts as a gatekeeper to
blood borne toxins (Brightman and Reese, 1969). Junctional pro-
teins, which include claudins, occludin and Junction Adhesion Mol-
ecules (JAMs), prevent transcellular transfer across the barrier.
Claudin-5, which is preferentially found in brain endothelial cell
membranes is crucial for maintaining barrier properties (Matter
and Balda, 2003), while deletion of claudin-5 in mice results in
size–dependent disruption of the blood brain barrier (Nitta et al.,
2003). Following stroke, blood brain permeability is enhanced in
older animals and tPA, the thrombolytic compound approved for
stroke treatment, further increases barrier permeability concomi-
tant with activation of occludin and claudin-5 (Kaur et al., 2011).
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In a cortical contusion injury, barrier permeability was greater in
aged animals as compared to young animals and was accompanied
by a reduction of claudin-5 but not occludin (Lee et al., 2012a).
However, no differences were found in the mRNA levels of claudin,
occludin or ZO1 between young, middle aged and old mice, nor
were there changes in the penetration of the anti-muscarinic drug
trospium chloride at any of these ages (Kranz et al., 2013). Aging
does impact the function of P-glycoprotein (Prg), a key efﬂux trans-
porter, however recent studies show that this may be restricted to
males (van Assema et al., 2012).
Consistent with the high demand for active transport in these
cells, barrier-forming endothelial cells contain signiﬁcantly greater
mitochondrial content than non-barrier forming endothelial cells
(Oldendorf et al., 1977). Elevated mitochondrial content is indica-
tive of transformation to barrier-type endothelial cells (Hayashi
et al., 1997) and is decreased in diseases such as multiple sclerosis
where the BBB permeability is increased (Claudio et al., 1989). In
both rats and monkey, mitochondrial content of endothelial cells
is reduced with age (Burns et al., 1981), while mitochondrial
DNA mutations increase during aging and in age-related neuro-
logic conditions such as Alzheimer’s disease (Muller et al., 2010).
Mitochondrial oxidative stress is a leading cause of vascular/
endothelial dysfunction in aging population. Brain endothelial cells
act as both source and target for reactive oxygen species (Strasser
et al., 1997; Haorah et al., 2007). With advancing age, the synthesis
of reactive oxygen species increases in endothelial cells (reviewed
in (Csiszar et al., 2008; Ungvari et al., 2007)), resulting in inactiva-
tion of the vasodilator nitric oxide (NO), and, consequently, re-
duced vasodilator capacity and perfusion of tissues (Csiszar et al.,
2005). Aging also increases iNOS in microvessels of hypertensive
subjects (Smith et al., 2011) and aging male rats (Cernadas et al.,
1998), often considered a compensation for reduced NO levels.
Age-related elevation of oxidative stress is accompanied by a
chronic low-grade inﬂammatory phenotype marked by NF-kB
activation (Ungvari et al., 2007). Furthermore, age-associated mito-
chondrial oxidative stress promotes mitochondrial protein oxida-
tion and mitochondrial DNA mutations [reviewed in (Dai and
Rabinovitch, 2009)], and is speculated to cause endothelial apopto-
sis (Yamamori et al., 2005; Lopez-Lopez et al., 2007). Decreased
density of cerebral arterioles in aging (Sonntag et al., 1997) is con-
sistent with the idea of vascular deterioration, although it remains
to be determined if this is directly related to endothelial oxidative
stress. The role of oxidative stress and stroke has been well docu-
mented (reviewed in Olmez and Ozyurt (2012)), however, there is
limited information on effects of midlife events such as menopause
on brain endothelium in the context of stroke. Estrogen treatment
to ovariectomized animals has been shown to reduce oxidative
stress in the hippocampus following ischemia (Zhang et al.,
2009), suggesting that the loss of ovarian hormones at menopause
may inﬂuence stroke severity through increased oxidative stress.
Evidence from in vitro studies (reviewed later) suggests that the
endothelium is a potential target of estrogen action.
1.2. Endothelial cells and cerebral blood ﬂow
Reduced cerebral blood ﬂowwith age has also been reported for
rats (Ohata et al., 1981; Berman et al., 1988) and monkeys (Noda
et al., 2002) and humans (Schultz et al., 1999). Interestingly, cere-
bral blood ﬂow reduction may occur as early as midlife (50 years)
(Schultz et al., 1999), consistent with elevated stroke risk during
this time frame. Through production of vasodilatory and vasocon-
strictive molecules, cerebrovascular endothelium plays an impor-
tant role in regulating blood ﬂow, which is also critical during
reperfusion following stroke (Gursoy-Ozdemir et al., 2012). The
discovery of nitric oxide a potent endothelial-derived vasodilatoryfactor (Ignarro et al., 1987) and EDHF (Bryan et al., 2005), as well as
the vasoconstrictor endothelin-1 (Yanagisawa et al., 1988) to-
gether constitute the most well-studied endothelial secretions.
Pathologic conditions that alter these effectors, especially the nitric
oxide system, impair vascular tone. The NO system is the target of
intensive study for the design of new drugs for cerebrovascular dis-
ease. One of the most prominent reasons for NO insufﬁciency is
age, due in part to the age-related reduction of nitric oxide syn-
thase (Pie et al., 2002) and an age-related increase in arginase, that
degrades the natural substrate for NOS (Berkowitz et al., 2003). In
fact age is the most signiﬁcant predictor of endothelial-dependent
vasodilation (Gerhard et al., 1996), although endothelial-indepen-
dent vasodilation is not affected by age. In coronary circulation,
endothelial-derived NO decreases dramatically in 70–80 years old
patients as compared to 20 years old patients (Egashira et al.,
1993), consistent with the observation that cerebral blood ﬂow is
negatively correlated with age in a study of 20–100 years old indi-
viduals (Tachibana et al., 1984). However, evidence from brachial
artery derived endothelium suggests that the age-related decline
in endothelial-dependent vasodilation in this vessel is inversely
correlated with ET-1 expression in brachial-derived endothelial
cells, while eNOS was not signiﬁcantly different with age. Further-
more, the ET-1 receptor antagonist BQ-123 restored 60% of the age-
related impairment in endothelial-dependent dilation, linking the
age response to elevation of vasoconstrictive, rather than vasodila-
tory factors (Donato et al., 2009). While this issue remains to be ex-
plored in cerebral vessels, it is also worth considering that age may
impair the response to these compounds. For example, adenosine
administration induced greater vasodilation in young animals as
compared to older animals (Jiang et al., 1992), while intravascular
serotonin exacerbates vasoconstriction in older animals (Hajdu
et al., 1993). Thus, the aging brain is more likely to be subject to
hypoperfusion and, potentially, greater neuronal damage.
While little information is available on the inﬂuence of mid-
life events such as menopause on endothelial dysfunction and
its role in cerebral blood ﬂow, reports suggest that estrogen af-
fects the NO system by increasing the expression of eNOS in cere-
bral arteries (Geary et al., 1998) and cerebral microvessels
(McNeill et al., 1999) and activates the PI3K-Akt-NO signaling
cascade in cerebral microvessels (Stirone et al., 2005), indicating
that the loss of this ovarian hormone at midlife will signiﬁcantly
impact cerebral vascular tone. However, recent studies using a
microﬂuidics approach cautions conclusions drawn from estro-
gens effects on a single cell type taken in isolation. Thus while
estradiol increases NO in endothelial cells, passaging erythrocytes
through chambers containing endothelial cells signiﬁcantly re-
duced NO synthesis by estradiol, possibly due to estradiol-medi-
ated decreases in ATP from erythrocytes (Letourneau et al.,
2010). Moreover, even among young animals where estrogen
treatment usually results in stroke neuroprotection, it is not usu-
ally thought to occur via alterations in cerebral blood ﬂow (Rusa
et al., 1999; Carswell et al., 2000).
Ovarian hormone effects on barrier function: While there is
clear evidence of age-associated disruption of blood brain barrier,
alterations in barrier function due to menopause or reproductive
senescence are relatively understudied. Menopause or reproduc-
tive senescence is associated with steep decline in ovarian hor-
mones, and will likely impact barrier and endothelial function
due to the known role of estrogen on this cell type. Experimental
studies evaluating the inﬂuence of estrogen on blood brain barrier
permeability generally indicate a protective function. Speciﬁcally,
17b-estradiol reduces barrier permeability following injury in
young female rodents (Liu et al., 2005), increases glucose uptake
and transport (Bishop and Simpkins, 1995; Shi et al., 1997), re-
duces ischemic- (Chi et al., 2002, 2005) and VEGF-induced (Chi
et al., 2004) leakiness of the blood–brain barrier in the cortex
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(Nishino et al., 1998) and in vitro (Mogami et al., 2002). 17b-
estradiol also reduces edema in an experimental stroke model
by reducing the activity (O’Donnell et al., 2006) and abundance
(Chang et al., 2008) of the Na-K-Cl cotransporter. Oral conjugate
estrogens also reduce vascular lesions and leukocyte permeability
caused by A-beta 40 and A beta-42 infusions (Rhodin et al., 2003).
However, estrogen acts synergistically with myelin basic protein
to cause mast cell inﬁltration into the brain parenchyma (Theoha-
rides et al., 1993) and the synthetic estrogen ethinyl estradiol is
shown to increase the endothelial permeability to albumin (Gam-
mal and Zuk, 1980).
Most of these studies assess the effects of estrogen in ovari-
ectomized young female animals, which models the surgical
menopause and may not completely recapitulate the natural
menopause. In a rodent model of reproductive senescence, we
ﬁnd that the effects of estrogen are not always neuroprotective
(Sohrabji, 2005). Reproductive aging is associated with increased
permeability of the blood brain barrier in the hippocampus and
olfactory bulb as compared to normally cycling young females
(Bake and Sohrabji, 2004). At the molecular/cellular level, this
is accompanied by increased perivascular IgG expression in hip-
pocampus, a commonly used marker to assess barrier integrity
in aging and disease. Furthermore, constitutive expression of
claudin-5 and occludin were not altered by age, however junc-
tional localization of these proteins, which is critical to their bar-
rier function was reduced in cerebral microvessels from middle
aged reproductive senescent females (Bake et al., 2009). In fact,
cerebral microvessels from a small sample of pre and post-men-
opausal women also conﬁrmed this reproductive age-related loss
of junctional localization (Bake et al., 2009). Disrupted tight
junctions are also seen in aging female hamsters (Gerrits et al.,
2010), although this is uncoupled from reproductive senescence.
1.3. Endothelial progenitor cells
Endothelial progenitor cells (EPCs) are immature endothelial
cells found in peripheral circulation (Asahara et al., 1997) that
are capable of repairing damaged endothelium during injury such
as cardiac infarction and stroke. EPCs are also thought to be a sur-
rogate or prognostic marker for endothelial dysfunction or vascular
diseases. Lower levels of circulating EPCs are positively correlated
with increases in age-related white matter lesions (Jickling et al.,
2009) and increased cardiovascular disease and reduced vascular
function (Hill et al., 2003; Schmidt-Lucke et al., 2005; Paul et al.,
2007). Conversely, CD34 EPC treatment also promotes angiogene-
sis, neurogenesis and better behavioral outcome in a stroke model
(Uemura et al., 2012). EPC are presumed to improve stroke out-
comes due to upregulation of trophic factors (Chopp and Li,
2002), and their ability to promote angiogenesis or vasculogenesis
(Chu et al., 2008). Thus conditions and disease that affect EPC
expression may also impair stroke recovery. For example, the pro-
portion and function of EPCs is affected by diabetes (Chen et al.,
2011), a major risk factor for cardiovascular and cerebrovascular
diseases, while the cholesterol-reducing drug statins increases
EPC’s during the acute phase of ischemic stroke (Sobrino et al.,
2012). Age-related changes in EPC levels have not been studied
extensively, but evidence indicates that although age does not af-
fect the number of EPC’s, their ability to migrate, proliferate and
survive are signiﬁcantly lowered in older subjects (61 y/o) as
compared to young subjects (25y/o) (Heiss et al., 2005), while
the atheroprotective properties of EPC are reduced in aging mice
(Rauscher et al., 2003). In a cardiac injury model, EPCs from young
mice were able to promote cardiac angiogenesis in older mice,
while EPCs from older donors did not (Edelberg et al., 2002). Thus
an important issue for further study is to determine whether theintrinsic capacity of EPCs is altered with age, or whether the aging
environment impedes EPC function.
Growth factors are critical for mobilizing EPCs from bone mar-
row to ischemic tissue and age-related decreases in SDF-1 and
VEGF as well deﬁcient HIF-1 signaling have been shown to impair
EPC trafﬁcking to ischemic sites (Chang et al., 2007). Age-related
changes in matrix molecules such as heparin sulfate also affect
migratory function of EPCs (Williamson et al., 2012). Furthermore,
the antioxidant capacity of EPCs is also impaired with age. Specif-
ically, levels and activity of the antioxidant enzyme glutathione
peroxidase-1 are much lower in EPCs derived from old subjects
(He et al., 2009) and are more susceptible to oxidative stress-in-
duced apoptosis.
Reproductive hormones also inﬂuence EPC function. Estrogen
and progesterone have been shown to improve EPC proliferation
in blood during the menstrual cycle (Matsubara and Matsubara,
2012) and EPC-mediated postnatal vasculogenesis (Masuda et al.,
2007). Estrogen promotes EPC-mediated reendothelialization
through nitric oxide following arterial injury in mice (Iwakura
et al., 2003) and improves EPC-mediated neovascularization in a
hind-limb ischemic model (Ruifrok et al., 2009). At post-
menopause, where estrogen levels are low, circulating EPC levels
were signiﬁcantly reduced as compared to pre-menopausal
women (Bulut et al., 2007). Similarly, EPCs are reduced in periph-
eral blood and bone marrow of ovariectomized mice, which can
be prevented with estrogen treatment (Strehlow et al., 2003).
Furthermore, estrogen reduces cell senescence through telomerase
activity (Imanishi et al., 2005). Decline of ovarian hormones at
menopause is thus likely to impact EPC function and subsequent
recovery from cardiac and cerebrovascular disease.
1.4. Aging and angiogenesis
Angiogenesis or formation of new vessels is an adaptative re-
sponse to ischemic injury (del Zoppo and Milner, 2006; Sonntag
et al., 2007). Hypoxia is a critical component of angiogenesis (Ka-
naan et al., 2006) and hypoxia induced upregulation of HIF-1 and
VEGF promotes endothelial cell growth (Pugh and Ratcliffe, 2003)
and ischemia induced angiogenesis (Greenberg, 1998). Post-stroke
angiogenesis is closely associated with neurogenesis (Zhang et al.,
2002, 2004; Chopp et al., 2007; Arai et al., 2011), such that the
angiogenic niche promotes neurogenesis (Palmer et al., 2000).
Neurons and astrocytes within the neurovascular unit also secrete
trophic factors such as IGF-1 (Li et al., 2010), VEGF (Ferrara et al.,
2003), and PDGF-b (Marti et al., 2000; Jin et al., 2002; Beck and
Plate, 2009) to induce angiogenesis, which in turn enhances prolif-
eration and differentiation of neuronal precursor cells to promote
neurogenesis (Sun et al., 2003). Co-cultures of rat brain endothelial
cells with subventricular zone neural progenitor cells also provides
indirect evidence that angiogenesis is coupled to neurogenesis
(Teng et al., 2008) and is required for brain recovery after stroke
(Xiong et al., 2010). Thus reduced functional capacity of endothe-
lial cells with age will not only affect vascular repair but also
neurogenesis.
Few studies have addressed the role of aging and angiogenesis
in the stroke brain, and the results are equivocal. Aged male
F344 rats show signiﬁcant decrease in capillary angiogenesis com-
pared to young animals following hypoxia (Ingraham et al., 2008),
while in mice, both young and aged animals display similar micro-
vessel densities 2–3 weeks after hypoxia, although hypoxia-in-
duced upregulation of HIF-1a and Ang-2 was signiﬁcantly
reduced in the aged mice (Benderro and Lamanna, 2011). Aging
also impairs the angiogenic potential of senescent human umbili-
cal vein endothelial cells (Garﬁnkel et al., 1996), which is associ-
ated with reduced VEGF levels (Rivard et al., 1999). An
experimental approach to replenish VEGF levels in aging mice,
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change in VEGF activated downstream signaling pathways (Gao
et al., 2009). Although HIF-1 activation is a primary step in angio-
genesis, PPAR-gamma coactivator 1-alpha is also capable of induc-
ing angiogenesis in aged F344 rats (Ndubuizu et al., 2010). Using
gene expression at the neurovascular unit as a marker for angio-
genic capacity, resting gene expression was lower in aging animals,
and the angiogenic response to hypoxia was also weaker in older
animals (Murugesan et al., 2012). Estrogen promotes angiogenesis
in many vascular beds, and has also been shown to decrease free
radical production, increase cell survival, and stimulate angiogen-
esis in cerebral endothelial cells (Krause et al., 2006). However
much less is known about the effects of estrogen on stroke-induced
angiogenesis. In a study examining the effect of estrogen on angi-
ogenesis and stroke, estrogen treatment increased Ang-1 and
microvessel density prior to stroke (Ardelt et al., 2005) and in-
creased microvessel density in the peri-infarct area at 10 days,
but not 1 day, post stroke (Ardelt et al., 2007).
1.5. Pericytes
Pericytes ensheath the capillary endothelial cells in the neuro-
vascular unit (Shepro and Morel, 1993; Armulik et al., 2005) and
play an important role in microcirculation (Hamilton et al., 2010)
and angiogenesis (Gerhardt and Betsholtz, 2003). Omission of peri-
cytes in the neurovascular unit using a PDGFRb deletion mice
showed impaired brain microcirculation and increased permeabil-
ity to TMR-conjugated dextran (40Kd) (Bell et al., 2010). Age-re-
lated neurodegeneration in this model was preceded by
degenerative changes in microvessels, underscoring the impor-
tance of this cell type to brain microvessel health. In an in vitro
BBB model, astrocytes and pericytes responded to hypoxia causing
endothelial cell death but pericytes were able to maintain the bar-
rier function better than astrocytes under prolonged oxygen depri-
vation (Al Ahmad et al., 2011). In reproductive senescent female
hamsters, vascular changes in endothelial cells and tight junctions
were paralleled by pericyte degeneration and thickening of the
basement membrane (Gerrits et al., 2010). Age and hormone re-
lated changes in this cell type thus represent another important
but understudied area that will impact stroke outcomes.
1.6. Astrocytes an active partner in brain dynamics
Originally described as merely a structural component of the
brain (see review Allen and Barres (2009), Volterra and Meldolesi
(2005), Dermietzel and Spray (1998)) our understanding and the
importance of astrocytes has advanced dramatically. Astrocytes
play a prominent role in regulation of synaptic activity (Ullian
et al., 2001; Ventura and Harris, 1999; Di Castro et al., 2011); extra-
cellular matrix secretion (Wujek and Akeson, 1987; Liesi and Sil-
ver, 1988), blood–brain barrier integrity (Janzer and Raff, 1987;
Kim et al., 2006 recent review), neurovascular coupling (Zonta
et al., 2003; Takano et al., 2006) and the inﬂammatory response
(Fontana et al., 1982; Robbins et al., 1987). Following brain injury
astrocytes become reactive with increased expression of glial
ﬁbrillary acidic protein (GFAP) (Petito et al., 1990; Singh and Math-
ew, 1989; Ordy et al., 1993; Takamiya et al., 1988). Astrocytes offer
trophic support through secretion and/or expression of several sol-
uble factors to include the neurotrophins (Lu et al., 1991; Yamak-
uni et al., 1987; Schwartz and Nishiyama, 1994; Riley et al.,
2004) growth factors (Garcia-Estrada et al., 1992; Ridet et al.,
1997; Banner et al., 1997; Zhang et al., 2006) or by regulating local
glutamate concentrations (Schousboe et al., 1977). Astrocytes are
also a source for inﬂammatory cytokines/chemokines (Lau and
Yu, 2001; Ridet et al., 1997; Ransohoff et al., 1993; Kim et al.,
1995) which can potentially support or potentiate the injuryresponse. The ability of astrocytes to offer either trophic support
or exacerbate the injury is dependent on several factors including
the extent of injury, age, hormonal status and any underlying
pathology. In this section, the inﬂuence of aging, hormonal status,
and sex-differences on astrocytes will be explored.
1.7. The aging astrocyte
The aging brain shows distinct changes in astrocyte morphol-
ogy (Vaughan and Peters, 1974), GFAP expression (Kohama et al.,
1995; Mandybur et al., 1989; Rozovsky et al., 1998; Nichols
et al., 1993) and astrocyte numbers (Mouton et al., 2002; Hansen
et al., 1987). Thus, astrocytes change over the lifetime and in the
context of neuroinﬂammation, this aging process may be detri-
mental to astrocyte function. As earlier reports show, aging alone
increases GFAP expression, however, increased astrocyte reactivity
also occurs following injury (Badan et al., 2003; Gordon et al.,
1997; Baldwin and Scheff, 1996; Topp et al., 1989) or chronic neu-
rodegeneration (Vijayan et al., 1991). Further, aging accelerates in-
jury-induced astrocyte reactivity (Badan et al., 2003; Popa-Wagner
et al., 2007; Gordon et al., 1997). Following focal ischemia this
exaggerated glial response coincides with accelerated glial scar for-
mation (Badan et al., 2003). In addition, matrix remodeling through
reduced expression of astrocyte-derived SC1, an extracellular ma-
trix-associated glycoprotein, may be impaired in aged rats follow-
ing focal ischemia (Lively et al., 2011).
Moreover, neurogenesis, a potential endogenous repair mecha-
nism following brain injury may also suffer in part due to reduced
astrocyte function with age. Decreased secretion of Wnt3, a protein
involved in neural stem cell differentiation, from astrocytes
resulted in impairments in hippocampal neurogenesis in aged
(9 mo.) mice as compared to young (3 mo.) mice (Okamoto et al.,
2011;Miranda et al., 2012). Reductions in astrocyte-derived growth
factors and their receptors such as insulin-like growth factor 1
(IGF-1) (Duenas et al., 1994; Lewis et al., 2012), ﬁbroblast growth
factor receptor 2 (FGFR-2) (Chadashvili and Peterson, 2006) and
vascular endothelial growth factor (VEGF) (Bernal and Peterson,
2011) may also contribute to reduced adult neurogenesis.
In vitro studies also show similar age-related dysregulation in
astrocytes. Ex vivo cultures of astrocytes collected from the olfac-
tory bulb of middle-aged female rats show increased stress ﬁber
formation, reduced laminin deposition, increased BDNF expression
and reduced TrkB expression compared to young astrocytes (Lewis
et al., 2008a) and more importantly, aged astrocytes show an
impairment in their ability to promote neuronal differentiation of
neural progenitor cells (Lewis et al., 2008a). Moreover, reduced
glutamate uptake has been reported in ex vivo adult, ischemia-
activated primary astrocyte cultures collected from 12 mo. old fe-
males that had been subjected to focal ischemia as compared to
astrocytes collected from similarly-treated young adults (Lewis
et al., 2012). Given that aged rats show increased infarct size
(Popa-Wagner et al., 2007; Selvamani and Sohrabji, 2010a), impair-
ments in glutamate clearance and metabolic dysregulation ob-
served in the aging astrocyte likely leads to a more toxic
microenvironment in the older brain.
1.8. Effects of sex hormones on astrocyte function
The sex (or gonadal) hormones androgen, estrogen and proges-
terone and their metabolites play a signiﬁcant role in regulating
astrocyte activity. Astrocyte morphology is altered by estradiol
(Amateau and McCarthy, 2002; Garcia-Segura et al., 1989) and tes-
tosterone (Amateau and McCarthy, 2002) and GFAP expression is
enhanced (Day et al., 1993; Satriotomo et al., 2004) or decreased
(Day et al., 1993) in the presence of sex steroids depending on
the treatment paradigm, region of interest and whether male or
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expression of astrocyte-derived growth factors (Platania et al.,
2005; Galbiati et al., 2003) and regulate the glial glutamate trans-
porters (Pawlak et al., 2005).
Given the effects these hormones have in the uninjured brain, it
is not surprising that they regulate astrocyte function following in-
jury. Several in vivo studies point to an attenuation of reactive
astrogliosis with hormone treatment. In gonadectomized male
rats, injury-induced reactive astrogliosis is attenuated following
replacement with estrogen, testosterone (Barreto et al., 2007;
Garcia-Estrada et al., 1993; Day et al., 1993), dihyrotestosterone
(Day et al., 1993) progesterone as well as the neurosteroids
dehydroepiandrosterone, pregnenolone and pregnenolone sulfate
(Garcia-Estrada et al., 1999). Estradiol was effective in reducing
gliosis in male mice following MPTP treatment, an injury model
for Parkinson’s disease (Tripanichkul et al., 2006). In addition, pro-
gesterone, estradiol (Garcia-Estrada et al., 1993) and the selective
estrogen modulators (SERMS) raloxifene and tamoxifen (Barreto
et al., 2009) reduced reactive gliosis in females. Following spinal
cord injury, progesterone reduced proliferation and activation of
astrocytes and microglia in male rats and increased OPC matura-
tion suggesting a role for progesterone in reducing reactive gliosis
and promoting myelin repair (Labombarda et al., 2011) and in
juvenile mice estrogen ameliorated the inﬂammatory response
through regulation of NF-jB in microglia and astrocytes following
a manganese-induced injury (Moreno et al., 2011). The estrogen-
mediated attenuation of astrogliosis following injury may be
driven in part by the endocannabinoid signaling system as
estrogen was ineffective in modulating the density and number
of reactive astrocytes in male rats when antagonists to the cannab-
inoid receptors CB1 or CB2 were used (Lopez Rodriguez et al.,
2011). Although not in the context of injury, ovariectomized
females given a single injection of testosterone propionate led to
reduced GFAP expression (Garcia-Segura et al., 1988). Estrogen
however did not reduce astrocyte accumulation in mice following
cuprizone-induced demyelination in the corpus callosum but did
reduce oligodendrocyte loss and delayed microglial accumulation
(Taylor et al., 2010).
Studies also suggest neuroprotective interventions of sex hor-
mones in vitro. In mixed-sex astrocyte primary cultures, up-regu-
lation of aquaporin-4 (AQP4), an astrocyte-speciﬁc water channel
was enhanced by testosterone but not 17b-estradiol after a 6 h
treatment (Gu et al., 2003). Increased AQP4 expression is linked
to increased brain edema and astrocyte swelling but in this study
although increased AQP4 expression increased there was a con-
comitant decrease in astrocyte osmotic fragility following testos-
terone treatment suggesting a neuroprotective role (Gu et al.,
2003). In the context of in vitro focal ischemia models, estradiol
application to mixed-sex astrocyte cultures reduced astrocyte
swelling following arginine vasopressin (AVP) treatment and hy-
poxia but was ineffective following aglycemia or oxygen-glucose-
deprivation (OGD) (Rutkowsky et al., 2011). Interestingly, here
estradiol reduced expression of AQP4 after 7 day but not at acute
(2–3 h) time points (Rutkowsky et al., 2011). Thus it is possible
AQP4 expression may have been modulated by 17b-estradiol in
the Gu et al. (2003) study had the treatment time been extended.
Cellular volume regulation has also been studied in female cortical
astrocyte cultures. In testosterone treated cultures, cell volume
regulation was normal while cells treated with estradiol or proges-
terone showed irregular volume regulation (Fraser and Swanson,
1994) suggesting that females may be more at risk for brain ede-
ma. Estradiol has also been shown to attenuate astrocyte-derived
release of nuclear transcription factor NF-jB (Dodel et al., 1999),
cytosolic Ca2+ (Arnold, 2005), interleukin(IL)-1b, tumor necrosis
factor (TNF)-a and matrix metalloproteinase-9 (Lewis et al.,
2008b) in inﬂammatory injury models.Sex hormones also act on astrocytes to up-regulate growth fac-
tors, genes and proteins that result in neuroprotective effects fol-
lowing injury. In spinal cord injury models, 17b-estradiol
increases protein expression of the glutamate transporter-1 (GLT-
1) in spinal cord astrocytes which in turn modulates the expression
of the potassium channel Kir4.1 in astrocytes thereby regulating
both local glutamate and potassium concentrations (Olsen et al.,
2010). In addition, manganese-induced impairments in the GLT-1
transporter, and subsequently glutamate uptake, are reversed in
cortical astrocyte cultures by both 17b-estradiol and tamoxifen
via increased expression of transforming growth factor alpha
(TGFa) (Lee et al., 2012b). In experimental autoimmune encepha-
lomyelitis (EAE) the neuroprotective effects of estrogen treatment
are due to signaling through estrogen receptor alpha (ERa) (Pola-
nczyk et al., 2003; Morales et al., 2006) speciﬁcally on astrocytes
(Spence et al., 2011). Deletion of ERa in astrocytes but not neurons
blocked the neuroprotective effects of systemic estrogen treat-
ment. Severe clinical disease and an increased inﬂammatory re-
sponse were observed in estrogen-treated mice lacking ERa in
astrocytes as compared to mice lacking ERa in neurons (Spence
et al., 2011). Interestingly, the neuroprotective interventions by
sex hormones may originate from the astrocyte itself or may result
from paracrine signaling. Aromatase expression, a key enzyme in
estrogen biosynthesis, is enhanced following a sub-lethal pressure
increase in astrocyte cultures (Gatson et al., 2011) while estrogen
treatment to astrocytes inhibits the steroid hydroxylase CYP7B1
which is responsible for metabolizing dehydroepiandrosterone
(DHEA) an important precursor for both estrogen and testosterone
(Fex Svenningsen et al., 2011). Taken together these data suggest
that sex hormones play a supportive role in astrocyte function,
and further support the hypothesis that the loss of ovarian hor-
mones at menopause may accelerate stroke severity in this
population.
1.9. Sex differences and astrocytes
As discussed above, in animal models both male and female
rodents respond to injury with increased GFAP expression and
both respond well to hormonal manipulation. Several studies in
rodents have examined sex differences in the context of injury,
and show differences in astrocyte proliferation (Zhang et al.,
2008), astrocyte reactivity (Barna et al., 1996; Cordeau et al.,
2008) and astrocyte survival (Nishino et al., 1998), however, the
results are divergent and the role of astrocytes is difﬁcult to
interpret.
In vitro mechanistic approaches have yielded more interpret-
able results. In neonatal primary astrocyte cultures derived from
male pups, androgenized female pups or vehicle-treated pups,
cytokine expression was increased by LPS treatment in male or
androgenized female cultures as compared to intact females
(Santos-Galindo et al., 2011). Neonatal mesensephalic astrocytes
collected from male mice treated with MPTP, a compound used
to mimic Parkinson’s disease, also showed an increased inﬂam-
matory proﬁle and increased cell death as compared to similarly
treated female astrocyte cultures (Sundar Boyalla et al., 2011).
Astrocytes derived from females but not males cleared signiﬁ-
cantly more glutamate through the GLAST transporter and motor
neurons seeded onto female astrocytes were less susceptible to
excess glutamate in the cultures (Morizawa et al., 2012). Follow-
ing OGD or oxidant cell death induced by H2O2, neonatal male
primary astrocyte cultures were more susceptible to cell death
as compared to age-matched female primary astrocyte cultures
(Liu et al., 2007). However, increased cell death was noted in
female astrocyte cultures when additional inﬂammatory media-
tors such as IL-1b or TNF-a were combined with OGD (Liu
et al., 2007). This sex difference may be due to higher aromatase
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(Liu et al., 2007). Recent data using adult ischemia-activated
cortical astrocytes showed that astrocytes derived from aged
females showed impairments in glutamate clearance as compared
to young female astrocyte cultures, however these same
impairments were not observed in age-matched male astrocyte
cultures (Lewis et al., 2012). In general, it appears that astrocytes
derived from females are better able to handle insults however
this is not true for all injury models and is likely brain region
dependent.
2. Summary and conclusion
Endothelial cells and astrocytes play a key role in the patho-
physiology of stroke. Endothelial cells act as a source and target
of neurotoxic substances in an ischemic environment, and play
a cardinal role in angiogenic repair, which is coupled to neuro-
genesis after stroke. Astrocytes also mediate the dynamic brain
response to injury, by providing trophic support to neurons in
the presence and absence of injury in part through regulation
by sex hormones. Aging, however, can lead to astrocyte and endo-
thelial dysregulation ultimately resulting in a toxic cellular envi-
ronment and potentially increased neuronal loss following injury.
The functional and anatomical interaction of endothelial cells and
astrocytes is crucial in the case of the blood brain barrier. The
blood brain barrier is severely impacted by ischemic stroke and
an important, yet understudied, issue is how the aging blood
brain barrier will impact neuronal survival in the ischemic brain
and, reciprocally, how stroke affects the aging blood brain barrier.
Despite the large amount of data now available on endothelial
and astrocyte function in stroke, there is little known about the
function of these cells under conditions that impact stroke sever-
ity. Thus, there is an urgent need for animal models that match or
duplicate the demographics most likely to have strokes or have
more severe strokes. Besides aging models, such studies need to
include other co-morbid conditions such as hypertension, high-
fat diet, hyperglycemia and other dietary deﬁciencies. From the
prevailing studies, it is clear that older animals sustain more se-
vere outcomes following stroke, which supports the use of these
models in more granular analysis of the cellular and molecular
changes that underlie these severe stroke effects. Similarly, die-
tary issue such as vitamin D deﬁciency (Balden et al., 2012),
high-fat diet (Li et al., 2013), hypertension (Carswell et al.,
2004) have all been successfully duplicated in animal models in
the context of stroke, and should be further employed to under-
stand the how these modiﬁable factors affect endothelial and
astrocyte function. Studies on an aging population are necessary
not only because it is the target population for ischemic disease,
but also because such comparative age analyses have the poten-
tial to uncover new therapeutic targets. A good example of this
strategy is the growth factor IGF-1, which is known to decrease
with aging in virtually all mammals, was also found to be neuro-
protective in stroke. In middle-aged female animals, the loss of
IGF-1 appears to alter the neuroprotective capacity of estrogen
(Selvamani and Sohrabji, 2010b).
In view of the data that stroke severity is worse in older women,
studies should include both males and females and the impact of
hormone loss and exogenous hormone treatment should be care-
fully studied in an aging model. While sex differences affect func-
tional capacity of support cells and sexually dimorphic responses
have been reported for therapeutic interventions in stroke models,
these differences need to be addressed in a more systematic man-
ner. In this context, new advances for live imaging (Cordeau et al.,
2008) and culturing of support cells (Foo et al., 2011) will be crit-
ical adjuncts for understanding how these cells contribute to or
hinder neuronal survival and brain repair.Acknowledgements
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